Initiating empagliflozin vs a DPP-4 inhibitor may slow the progression of diabetic retinopathy in patients with type 2 ...
A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be ...